Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United StatesJames A. Karlowsky, Daniel F. Sahm, Laurie J. Kelly et al.|Antimicrobial Agents and Chemotherapy|2002Cited by 369
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001James A. Karlowsky, Daniel F. Sahm, Deborah C. Draghi et al.|Antimicrobial Agents and Chemotherapy|2003Cited by 352
Multidrug-Resistant Urinary Tract Isolates of <i>Escherichia coli:</i> Prevalence and Patient Demographics in the United States in 2000Daniel F. Sahm, James A. Karlowsky, Clyde Thornsberry et al.|Antimicrobial Agents and Chemotherapy|2001Cited by 299
Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)Mark E. Jones, Richard P. Wenzel, Deborah C. Draghi et al.|Annals of Clinical Microbiology and Antimicrobials|2004Cited by 272
<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016Meredith Hackel, Daniel F. Sahm, Masakatsu Tsuji et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 234